治疗耐药抑郁症的下一步治疗选择:来自梅奥诊所抑郁症中心小组的见解
Matheus G Marques1, Aysegul Özerdem1, Simon Kung1
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.
The Journal of clinical psychiatry
|January 28, 2026
概括
耐治疗抑郁症 (TRD) 缺乏明确的定义,使护理复杂化. 专家的共识建议增加抗精神病药物,TMS或胺,根据标准指南之外的患者因素量身定制.
科学领域:
- 精神病学是一个精神病学.
- 临床神经科学 临床神经科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐治疗性抑郁症 (TRD) 影响了相当一部分主要抑郁症患者,增加了发病率和自杀风险.
- 对TRD缺乏标准化的定义使治疗选择和优先考虑变得复杂.
- 现有的指导方针提供了广泛的治疗类别,在新的干预措施和复杂的临床情景中存在持续的证据差距.
研究的目的:
- 通过建模修改的Delphi共识,提供对TRD治疗选择的临床视角.
- 解决TRD标准化定义和治疗优先级的差距.
- 探索有关TRD下一步治疗策略的专家意见.
主要方法:
- 一个基于案例的模拟讨论,涉及10名在梅奥诊所抑郁症中心专门从事TRD治疗的精神病医生.
- 在三次失败的抗抑郁药试验后,使用TRD患者的结构化临床细节对下一步治疗选择进行代排名.
- 三轮匿名调查,中间有小组讨论,包括六种反映代谢疾病和年龄等临床考虑的图片变化.
主要成果:
- 强烈的共识支持使用第二代抗精神病药物,跨磁刺激 (TMS) 和胺/胺作为TRD的初始下一步治疗.
- 根据患者特征调整治疗偏好,包括非增强型抗抑郁药和电疗法 (ECT).
- 专家意见强调,需要将TRD战略定制到超越传统的指导层.
结论:
- 将TRD的治疗策略与个体患者的因素相适应,对于有效的护理至关重要.
- 整合多学科观点和患者偏好可以提高TRD的治疗选择.
- 这种专家共识为治疗耐药抑郁症的个性化护理提供了宝贵的见解.
相关概念视频
Long-term Depression
33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Long-term Depression
3.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.3K
Freezing Point Depression and Boiling Point Elevation
39.9K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.9K
Depressants
418
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
418
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Depression: Overview
871
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
871


